Smart Dalton E. III
SEC CIK 2003375 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck & Co. | SVP Fin. - Gbl Ctrl | 9,520 | — | $1.12M | 19 | 2024-01-22 | 2026-05-02 |
Most active insiders at MRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zachary Jennifer | EVP, GC | — | $25.20M |
| 2 | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | — | $11.29M |
| 3 | Guindo Chirfi | EVP, Access, Policy, Comms | — | $8.15M |
| 4 | Williams David Michael | EVP, Chief Info, Digital Off | — | $8.13M |
| 5 | Davis Robert M | COB, CEO, Pres, Dir | — | $5.60M |
| 6 | Litchfield Caroline | EVP, CFO | — | $5.02M |
| 7 | Li Dean Y | Pres, Executive VP, MRL | — | $2.99M |
| 8 | Maraldo David R. | EVP, Pres. MMD | — | $2.41M |
| 9 | Oosthuizen Johannes Jacobus | Pres, U.S. Market | — | $1.83M |
| 10 | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | — | $766.0K |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 13:51 | 2026-05-02 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | M - OptEx | $112.16 | +383 | 9,520 | +4% | +$43.0K |
| D | 2026-05-05 13:51 | 2026-05-02 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | F - Tax | $112.16 | -132 | 9,388 | -1% | -$14.8K |
| DM | 2026-05-01 17:55 | 2026-04-29+ | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | M - OptEx | $110.33 | +1,408 | 9,296 | +18% | +$155.3K |
| DM | 2026-05-01 17:55 | 2026-04-29+ | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | F - Tax | $110.33 | -483 | 9,137 | -5% | -$53.3K |
| DM | 2026-02-06 | 2026-02-04 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | S - Sale+OE | $119.68 | -6,400 | 10.6K | -38% | -$766.0K |
| D | 2026-02-06 | 2026-02-04 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | M - OptEx | $62.07 | +4,000 | 14.6K | +38% | +$248.3K |
| 2026-01-28 | 2026-01-26 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | A - Grant | $107.40 | +1,066 | 10.6K | +11% | +$114.5K | |
| DM | 2025-05-05 | 2025-05-03 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | M - OptEx | $83.18 | +2,050 | 10.1K | +25% | +$170.5K |
| DM | 2025-05-05 | 2025-05-03 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | F - Tax | $83.18 | -844 | 9,539 | -8% | -$70.2K |
| DM | 2025-05-02 | 2025-04-30+ | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | M - OptEx | $84.06 | +845 | 8,242 | +11% | +$71.0K |
| DM | 2025-05-02 | 2025-04-30+ | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | F - Tax | $84.06 | -290 | 8,083 | -3% | -$24.4K |
| D | 2025-04-29 | 2025-04-25 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | M - OptEx | $58.08 | +5,000 | 12.0K | +71% | +$290.4K |
| D | 2025-04-29 | 2025-04-25 | MRK | Merck & Co. | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | S - Sale+OE | $82.76 | -4,262 | 7,778 | -35% | -$352.7K |
| 2025-01-29 | 2025-01-27 | MRK | Merck & Co. | Smart Dalton | SVP Fin. - Gbl Ctrl | A - Grant | $97.94 | +2,586 | 7,014 | +58% | +$253.3K | |
| DM | 2024-05-06 | 2024-05-03+ | MRK | Merck & Co. | Smart Dalton | SVP Fin. - Gbl Ctrl | M - OptEx | $128.09 | +2,658 | 4,708 | +130% | +$340.5K |
| DM | 2024-05-06 | 2024-05-03+ | MRK | Merck & Co. | Smart Dalton | SVP Fin. - Gbl Ctrl | F - Tax | $128.06 | -1,147 | 4,118 | -22% | -$146.9K |
| D | 2024-05-02 | 2024-05-02 | MRK | Merck & Co. | Smart Dalton | SVP Fin. - Gbl Ctrl | M - OptEx | $128.80 | +381 | 3,048 | +14% | +$49.1K |
| D | 2024-05-02 | 2024-05-02 | MRK | Merck & Co. | Smart Dalton | SVP Fin. - Gbl Ctrl | F - Tax | $128.80 | -131 | 2,917 | -4% | -$16.9K |
| 2024-01-24 | 2024-01-22 | MRK | Merck & Co. | Smart Dalton | SVP Fin. - Gbl Ctrl | A - Grant | $119.43 | +2,661 | 2,667 | +42,576% | +$317.8K |
Purchase Sale Sale after option exercise All abbreviations